| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.097 | 0.04 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.031 | 0.5 |